DNAJB1 and melanoma: A study comparing the expression levels of HSPs across patient clinical parameters showed that, with the notable exception of HSP32, whose expression correlated with improved patient survival, increased expression of HSP90 and HSP40 correlated with advanced stages of melanoma, and in the case of HSP40 with decreased patient survival (105).